Pacira BioSciences, Inc. Quarterly Interest Expense in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Pacira BioSciences, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q1 2024.
  • Pacira BioSciences, Inc. Interest Expense for the quarter ending March 31, 2024 was $3.32M, a 65.4% decline year-over-year.
  • Pacira BioSciences, Inc. Interest Expense for the twelve months ending March 31, 2024 was $14M, a 64.3% decline year-over-year.
  • Pacira BioSciences, Inc. annual Interest Expense for 2023 was $20.3M, a 49.2% decline from 2022.
  • Pacira BioSciences, Inc. annual Interest Expense for 2022 was $40M, a 25.9% increase from 2021.
  • Pacira BioSciences, Inc. annual Interest Expense for 2021 was $31.8M, a 23.7% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $14M $3.32M -$6.27M -65.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $20.3M $3.39M -$7.65M -69.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $28M $3.46M -$6.39M -64.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $34.4M $3.87M -$4.97M -56.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $39.3M $9.59M -$657K -6.41% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $40M $11M +$618K +5.93% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $39.4M $9.86M +$2.52M +34.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $36.8M $8.83M +$1.81M +25.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $35M $10.2M +$3.28M +47% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $31.8M $10.4M +$3.36M +47.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $28.4M $7.33M +$201K +2.82% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $28.2M $7.02M +$1.57M +28.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $26.6M $6.97M +$949K +15.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $25.7M $7.06M +$1.07M +17.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $24.6M $7.13M +$1.19M +20.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $23.4M $5.46M -$422K -7.18% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $23.8M $6.02M +$208K +3.58% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $23.6M $6M +$243K +4.22% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $23.4M $5.94M +$298K +5.28% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $23.1M $5.88M +$481K +8.91% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $22.6M $5.81M +$657K +12.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $21.9M $5.75M +$648K +12.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $21.3M $5.64M +$515K +10% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $20.8M $5.4M +$171K +3.27% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $20.6M $5.16M +$2.57M +99.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $18M $5.11M +$3.25M +175% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $14.8M $5.13M +$3.53M +220% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $11.3M $5.23M +$3.49M +202% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $7.78M $2.59M +$721K +38.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $7.06M $1.86M -$25K -1.33% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $7.09M $1.6M -$304K -16% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $7.39M $1.73M -$207K -10.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $7.6M $1.87M -$128K -6.41% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $7.73M $1.88M -$6.39M -77.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $14.1M $1.91M -$132K -6.48% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $14.3M $1.94M -$139K -6.69% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $14.4M $2M -$111K -5.27% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $14.5M $8.28M +$6.35M +329% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $8.15M $2.04M +$145K +7.66% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 $8.01M $2.08M +$165K +8.62% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 $7.84M $2.11M +$588K +38.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-30
Q4 2013 $7.25M $1.93M +$1.59M +462% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-25
Q3 2013 $5.67M $1.89M +$1.44M +315% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-30
Q2 2013 $4.23M $1.91M +$1.42M +287% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 $2.81M $1.52M +$1.01M +196% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $1.81M $343K -$370K -51.9% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $2.18M $456K -$454K -49.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
Q2 2012 $2.63M $494K -$182K -26.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $2.81M $514K -$1.97M -79.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $4.78M $713K Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $910K -$167K -15.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 $676K -$211K -23.8% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $2.48M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 $1.08M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $887K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.